Search research articles
Contact Us
Filters
Showing results (181-190 of 224) with videos related to
Page
of 23
Sort By:
Mbio
|
June 16, 2016
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models
Tania Rivera-Hernandez, Manisha Pandey, Anna Henningham, et al.
Clinical and Translational Science
|
July 30, 2024
Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials
Matthew P Kosloski, Emma Guttman-Yassky, Michael J Cork, et al.
BMJ Open
|
August 23, 2019
Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial
Zarif K Jabbar-Lopez, Nikeeta Gurung, Danielle Greenblatt, et al.
Pediatric Dermatology
|
December 4, 2019
Diaper dermatitis prevalence and severity: Global perspective on the impact of caregiver behavior
Andrew N Carr, Thomas DeWitt, Michael J Cork, et al.
Vaccines
|
April 27, 2024
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A <i>Streptococcus</i> Pharyngeal Infection in a Non-Human Primate Model
Tania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, et al.
Journal of the American Academy of Dermatology
|
July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study
Alan D Irvine, Amy S Paller, Elaine C Siegfried, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 7, 2019
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion
J P Thyssen, M S de Bruin-Weller, A S Paller, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
November 9, 2020
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical Trials
Jonathan I Silverberg, Eric L Simpson, Emma Guttman-Yassky, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
April 25, 2012
Conserved anchorless surface proteins as group A streptococcal vaccine candidates
Anna Henningham, Emiliano Chiarot, Christine M Gillen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 6, 2019
Detection of Epidemic Scarlet Fever Group A Streptococcus in Australia
Mark J Walker, Stephan Brouwer, Brian M Forde, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 224) with videos related to
Sort By:
Page
of 23
Mbio
|
June 16, 2016
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models
Tania Rivera-Hernandez, Manisha Pandey, Anna Henningham, et al.
Clinical and Translational Science
|
July 30, 2024
Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials
Matthew P Kosloski, Emma Guttman-Yassky, Michael J Cork, et al.
BMJ Open
|
August 23, 2019
Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial
Zarif K Jabbar-Lopez, Nikeeta Gurung, Danielle Greenblatt, et al.
Pediatric Dermatology
|
December 4, 2019
Diaper dermatitis prevalence and severity: Global perspective on the impact of caregiver behavior
Andrew N Carr, Thomas DeWitt, Michael J Cork, et al.
Vaccines
|
April 27, 2024
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A <i>Streptococcus</i> Pharyngeal Infection in a Non-Human Primate Model
Tania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, et al.
Journal of the American Academy of Dermatology
|
July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study
Alan D Irvine, Amy S Paller, Elaine C Siegfried, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 7, 2019
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion
J P Thyssen, M S de Bruin-Weller, A S Paller, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
November 9, 2020
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical Trials
Jonathan I Silverberg, Eric L Simpson, Emma Guttman-Yassky, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
April 25, 2012
Conserved anchorless surface proteins as group A streptococcal vaccine candidates
Anna Henningham, Emiliano Chiarot, Christine M Gillen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 6, 2019
Detection of Epidemic Scarlet Fever Group A Streptococcus in Australia
Mark J Walker, Stephan Brouwer, Brian M Forde, et al.
Page
of 23